Thus, targeting ALDH1A1 expression to reduce the abundance of toxic dopamine metabolites could serve as a preventive strategy for PD (Carmichael et al., 2021; Fan et al., 2022). This evidence concerns the gene ALDH1A1 and Parkinson disease.